Form 4 for IVDA Iveda Solutions, Inc.
Accepted 2021-09-27 00:00:00 ET · period of report 2021-09-23 · accession 0001493152-21-023791 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-27 | 2017-06-30+ | IVDA | BRILON ROBERT J | CFO | M - OptEx | $0.2654 | +794.0K | 320.0K | New | +$210.7K |
| DM | 2021-09-27 | 2020-12-07 | IVDA | BRILON ROBERT J | CFO | M - OptEx | $0.00 | -320.0K | 0 | -100% | $0 |
| DM | 2021-09-27 | 2017-12-29+ | IVDA | BRILON ROBERT J | CFO | A - Grant | $0.00 | +420.0K | 200.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2017-06-30 | M | A | 473,988 | $0.35 | 473,988 | D | — | — | (F2) Common stock was acquired from conversion of Series A Preferred Shares |
| 2 | Common | Common Stock | 2020-12-07 | M | A | 320,000 | $0.14 | 320,000 | D | — | — | (F1) Common stock was acquired from exercise of options. |
| 3 | Derivative | Options (Right to Buy) | 2020-12-07 | M | D | 100,000 | $0.00 | 0 | D | $0.14 · 2018-12-28 to 2028-12-28 | 100,000 Common Stock | |
| 4 | Derivative | Options (Right to Buy) | 2020-12-07 | M | D | 100,000 | $0.00 | 0 | D | $0.14 · 2016-12-29 to 2026-12-29 | 100,000 Common Stock | |
| 5 | Derivative | Options (Right to Buy) | 2019-12-20 | A | A | 20,000 | $0.00 | 20,000 | D | $0.28 · 2019-12-20 to 2029-12-20 | 20,000 Common Stock | (F3) The options subject to these grants vested 100% on the date of the grant. |
| 6 | Derivative | Options (Right to Buy) | 2018-12-28 | A | A | 100,000 | $0.00 | 100,000 | D | $0.04 · 2018-12-28 to 2028-12-28 | 100,000 Common Stock | (F3) The options subject to these grants vested 100% on the date of the grant. |
| 7 | Derivative | Options (Right to Buy) | 2017-12-29 | A | A | 100,000 | $0.00 | 100,000 | D | $0.1 · 2017-12-29 to 2027-12-29 | 100,000 Common Stock | (F3) The options subject to these grants vested 100% on the date of the grant. |
| 8 | Derivative | Options (Right to Buy) | 2020-12-15 | A | A | 200,000 | $0.00 | 200,000 | D | $0.37 · 2020-12-15 to 2030-12-15 | 200,000 Common Stock | (F3) The options subject to these grants vested 100% on the date of the grant. |
| 9 | Derivative | Options (Right to Buy) | 2020-12-07 | M | D | 20,000 | $0.00 | 0 | D | $0.14 · 2019-12-20 to 2029-12-20 | 20,000 Common Stock | |
| 10 | Derivative | Options (Right to Buy) | 2020-12-07 | M | D | 100,000 | $0.00 | 0 | D | $0.14 · 2017-12-19 to 2017-12-19 | 100,000 Common Stock |